cris.boxmetadata.label.title
A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico
cris.boxmetadata.label.dateissued
15 browse.startsWith.months.february 2009
cris.boxmetadata.label.accesslevel
metadata only access
cris.boxmetadata.label.resourcetype
journal article
cris.boxmetadata.label.authors
Mohamed J.A.
DuPont H.L.
Jiang Z.D.
Flores J.
Carlin L.G.
Belkind-Gerson J.
Martinez-Sandoval F.G.
Guo D.
Okhuysen P.C.
University of Texas Medical Branch
cris.boxmetadata.label.publisher
Oxford University Press
cris.boxmetadata.label.abstract
Background. Osteoprotegerin (OPG), an immunoregulatory member of the TNF receptor superfamily, is expressed in inflamed intestinal mucosa. We investigated whether OPG is produced by intestinal epithelial cells and tested the hypothesis that single-nucleotide polymorphisms (SNPs) in the gene encoding OPG (TNFRSF11B) are associated with traveler's diarrhea (TD) among North American travelers to Mexico. Methods. OPG concentration was measured in the supernatants of T84 cells infected with various diarrheagenic Escherichia coli pathotypes. Genotyping was performed for 4 SNPs in the OPG gene for 968 North American travelers with or without TD. Stool samples from travelers with TD were evaluated for the presence of enteric pathogens. Results. T84 cells produced higher OPG levels in response to infection with various diarrheagenic E. coli pathotypes than with E. coli controls (P < .05). A SNP in the exon 1 region of the OPG gene (OPG +1181G>C) was associated with TD in white travelers who stayed in Mexico for >1 week during the summer (P = .009) and for TD due to nonsecretory pathogens (P = .001). Conclusions. Our study suggests that OPG is secreted by intestinal epithelial cells in response to enteropathogens and that a polymorphism in the OPG gene is associated with an increased susceptibility to TD. © 2009 by the Infectious Diseases Society of America. All rights reserved.
cris.boxmetadata.label.citationstartpage
477
cris.boxmetadata.label.citationendpage
485
cris.boxmetadata.label.volume
199
cris.boxmetadata.label.issue
4
cris.boxmetadata.label.language
English
cris.boxmetadata.label.ocdeknowledgeArea
Enfermedades infecciosas
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-61849158210
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
Journal of Infectious Diseases
cris.boxmetadata.label.containerissn
00221899
cris.boxmetadata.label.sponsor
Received 28 March 2008; accepted 9 September 2008; electronically published 7 January 2009. Potential conflicts of interest: none reported. Presented in part: 45th Annual Meeting of Infectious Diseases Society of America, San Diego, 4–7 October, 2007 (abstract 458). Financial support: National Institutes of Health (grant R01 AI54948–01 to P.C.O., grant UL1RR024148 to the Center for Clinical and Translational Sciences of the University of Texas Medical School at Houston, and grant DK56338 to fund the Texas Gulf Coast Digestive Diseases Center). Reprints or correspondence: Dr. Pablo C. Okhuysen, Div. of Infectious Diseases, The University of Texas Medical School, 6431 Fannin St., MSB 2.112, Houston, TX (Pablo.C.Okhuysen@uth.tmc.edu).
peru-layout.shadow-copies
Directorio de Producción Científica
Scopus